A string of proposed transactions could mean the value of shares leaving the local bourse exceeds new listings and raises for ...

Aeluma is transitioning from a science project toward early commercialization, where milestone progression matters more than ...

Nationally, winter is the sleepiest season for the housing market, but some home buyers still get it done. About 13,000 ...

These four Warren Buffett favorite stocks are good growth and income investments to acquire now and hold in a portfolio ...

Because Broadcom sells both chips and software solutions, it has diversified revenue streams that give it a competitive moat.

If you’ve ever sat in the dark at 3 AM, clutching a mouse and staring at a pixels-wide gap in a smoke on Overpass, you know ...

Learn what a funding cover is, how it helps insurers manage risk with excess-of-loss reinsurance, and the investment benefits it offers for self-funding claims.

On Jan. 21, 2026, the market weighed ImmunityBio’s skyrocketing share price, surging volume, and the company's heavily-shorted stock.

Just when income investors were ready to give up on the bond market, it went and had its best year since 2020. The outlook is good for 2026, too, despite some growing risks.

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

What To Know: The intense price action is characteristic of a price discovery phase for the newly listed company, exacerbated by a relatively small float and high speculative interest. Trading volume ...

It’s been a good year to be a Dog of the Dow—especially for dividend investors. The ten highest-yielding stocks in the Dow Jones Industrial Average are up an average of 17.8% in 2025 through Friday, ...